Profile
Full Name
Actuate Therapeutics, Inc. Common stockTicker Symbol
ACTUExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
August 13, 2024Indexes
Not includedEmployees
10Key Details
Price
$8.00(-2.79%)
Market cap
$156.25M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$3.26(-151.80% YoY)
PE ratio
-
Next earnings date
May 30, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Actuate Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 17, 25 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Actuate Therapeutics?
- Does Actuate Therapeutics pay dividends?
- What sector is Actuate Therapeutics in?
- What industry is Actuate Therapeutics in?
- What country is Actuate Therapeutics based in?
- When did Actuate Therapeutics go public?
- Is Actuate Therapeutics in the S&P 500?
- Is Actuate Therapeutics in the NASDAQ 100?
- Is Actuate Therapeutics in the Dow Jones?
- When was Actuate Therapeutics's last earnings report?
- When does Actuate Therapeutics report earnings?
- Should I buy Actuate Therapeutics stock now?
What is the ticker symbol for Actuate Therapeutics?
The ticker symbol for Actuate Therapeutics is NASDAQ:ACTU
Does Actuate Therapeutics pay dividends?
No, Actuate Therapeutics does not pay dividends
What sector is Actuate Therapeutics in?
Actuate Therapeutics is in the Healthcare sector
What industry is Actuate Therapeutics in?
Actuate Therapeutics is in the Biotechnology industry
What country is Actuate Therapeutics based in?
Actuate Therapeutics is headquartered in United States
When did Actuate Therapeutics go public?
Actuate Therapeutics's initial public offering (IPO) was on August 13, 2024
Is Actuate Therapeutics in the S&P 500?
No, Actuate Therapeutics is not included in the S&P 500 index
Is Actuate Therapeutics in the NASDAQ 100?
No, Actuate Therapeutics is not included in the NASDAQ 100 index
Is Actuate Therapeutics in the Dow Jones?
No, Actuate Therapeutics is not included in the Dow Jones index
When was Actuate Therapeutics's last earnings report?
Actuate Therapeutics's most recent earnings report was on Nov 13, 2024
When does Actuate Therapeutics report earnings?
The next expected earnings date for Actuate Therapeutics is May 30, 2025
Should I buy Actuate Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions